SoVote

Decentralized Democracy

House Hansard - 332

44th Parl. 1st Sess.
June 14, 2024 10:00AM
  • Jun/14/24 12:02:00 p.m.
  • Watch
Madam Speaker, Health Canada's priority review program exists to allow the expedited review of new, potentially life-saving, therapies. Qualifying drug submissions are able to seek approval for therapeutic use in advance of other, less urgent therapies. Health Canada's posted timeframe for this expedited process is a target of 180 calendar days. How often is Health Canada meeting this target? How often has this target been missed in each of the years since the priority review program was established?
81 words
  • Hear!
  • Rabble!
  • star_border
  • Jun/14/24 12:02:33 p.m.
  • Watch
Madam Speaker, I want to thank the member opposite for asking a really important question. I know he has asked similar questions before. As I said earlier in the House, our focus is to make sure that we approve medications through Health Canada, but do so in a manner that maintains the safety of medications for Canadians. We cannot afford to ever take shortcuts that could jeopardize the lives of Canadians. Of course, through the pandemic, we learned a lot of lessons. We are looking at ways to improve the approval process, and we will continue to work on that.
100 words
  • Hear!
  • Rabble!
  • star_border